With Measles Roaring Back, the Search for a Drug is On
As vaccination rates decline, biotech companies see a potential new market for measles drugs.

© Claire Merchlinsky/The New York Times; Photographs via Getty

© Claire Merchlinsky/The New York Times; Photographs via Getty

© The New York Times